You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 111 No. 4, April 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Mitomycin and Fluorouracil With Concomitant Radiotherapy in Head and Neck Cancer

Michael J. Kaplan, MD; Seung S. Hahn, MD; Michael E. Johns, MD; F. Marc Stewart, MD; William C. Constable, DMRT; Robert W. Cantrell, MD; BYRON J. BAILEY, MD

Arch Otolaryngol. 1985;111(4):220-222.


Abstract

• Forty-two previously untreated patients with predominantly stage IV (35) head and neck squamous cell carcinoma were treated preoperatively with mitomycin and fluorouracil and concomitant radiotherapy with 5,000 to 6,000 rad using a split-course technique. Toxic reactions were acceptable. Five patients developed severe mucositis. The white blood cell count fell to 1,500/cu mm in two patients; the platelet count fell to 100,000/cu mm in three. Other complications occurred in three patients. Eightysix percent of patients completed advised treatment. Complete response, assessed clinically and with histologic correlation, was 79% at primary sites and 69% at nodal sites. Twenty-seven patients had a complete response (64%). Follow-up currently is between ten and 24 months. Though analysis of disease-free intervals and survival data is premature, the high complete response rates in this study are encouraging.

(Arch Otolaryngol 1985;111:220-222)



Author Affiliations

Galveston, Tex

From the Department of Otolaryngology—Head and Neck Surgery (Drs Kaplan, Johns, and Cantrell), Division of Therapeutic Radiology and Oncology (Drs Hahn and Constable), and the Division of Hematology and Oncology (Dr Stewart), University of Virginia Medical Center, Charlottesville. Dr Kaplan is currently at the University of California School of Medicine, San Francisco. Dr Johns is currently at The Johns Hopkins Hospitals, Baltimore.


Footnotes

Accepted for publication Jan 8, 1985.

Read before the international conference on Head and Neck Cancer, Baltimore, July 23, 1984.

Reprint requests to Department of Otolaryngology and Maxillofacial Surgery, Box 430, University of Virginia Medical Center, Charlottesville, VA 22908 (Dr Cantrell).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.